跳至主要内容
临床试验/JPRN-jRCT2080222575
JPRN-jRCT2080222575已完成3 期

Confirmatory study of EN-P05 in patients with tube feeding.

EN Otsuka Pharmaceutical Co.,Ltd.0 个研究点目标入组 112 人开始时间: 2014年8月28日最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
112

研究概览

简要总结

EN-P05 was not considered to be a nutrition support formula similar to DA-8902, because the proportion of patients who were out of tolerance interval in TTR among the primary outcome was over 10%.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • (1)Patients needed enteral nutrition support with tube feeding.
  • (2)Patients able to stay at the study site from the day before the start of the run-in observation period until completion of post-dosing examination.
  • (3)Patients aged 20years old or more.
  • (4)Patients or the legal representative capable of giving informed consent to participate in the study of their own free will.

排除标准

  • (1)Patients with ileus.
  • (2)Patients with severe intestinal dysfunction or loss of intestinal function.
  • (3)Patients with congenital abnormalities in amino and metabolism.
  • (4)Patients with a history of hypersensitivity to any ingredients of study drugs.
  • (5)Patients who are pregnant or hope for pregnancy.
  • (6)Patients with severe heart disease , severe hematological disorder , severe renal dysfunction, severe liver dysfunction, and malignant tumor.
  • (7)Patients with heart failure associated with nausea, vomiting, and diarrhea.
  • (8)Patients with acute nephritis, nephrosis or end-stage renal failure that require strict protein and electrolyte restrictions.
  • (9)Patients with abnormalities in carbohydrate metabolism including severe diabetes mellitus.
  • (10)Patients who are not expected to take an enteral nutrition for more than 10 days prior to study drug administration.
  • (11)Patients with a surgical history of esophagus, stomach, intestines, liver, or pancreas resection except for slight resection such as polyp, appendectomy, gastrostomy, nissen fundoplication.
  • (12)Patients with chronic diarrhea such as inflammatory bowel disease.
  • (13)Patients with pneumonia.
  • (14)Patients with difficulties in taking sufficient amount of blood for clinical trial.
  • (15)Patients participated in other clinical trials within 6 months before obtaining informed consent.
  • (16)Patients who are judged by investigator to be excluded.

研究者

相似试验